A detailed history of Terril Brothers, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Terril Brothers, Inc. holds 808 shares of LLY stock, worth $642,901. This represents 0.26% of its overall portfolio holdings.

Number of Shares
808
Holding current value
$642,901
% of portfolio
0.26%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

BUY
$525.19 - $619.13 $225,306 - $265,606
429 Added 113.19%
808 $470,000
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $164,751 - $227,134
379 New
379 $203,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Terril Brothers, Inc. Portfolio

Follow Terril Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Terril Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Terril Brothers, Inc. with notifications on news.